The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Neurovascular Embolization Devices Market Between 2026 And 2030?
The neurovascular embolization devices market size has experienced robust growth recently. It is projected to expand from $1.38 billion in 2025 to $1.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. This historical expansion can be linked to factors such as the increasing prevalence of cerebral aneurysms, a rise in neurointerventional procedures, enhanced availability of skilled neurovascular specialists, greater hospital investments in advanced neurocare, and the broader adoption of minimally invasive stroke treatments.
The neurovascular embolization devices market is projected to experience significant expansion in the coming years. It is anticipated to grow to $1.91 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. This growth throughout the forecast period stems from factors such as increasing demand for advanced stroke management solutions, rising investments in neurovascular research and development, an expanding aging population afflicted with vascular disorders, the growing adoption of next-generation embolization devices, and a heightened focus on improving procedural outcomes. Dominant trends during this period involve the increasing uptake of flow diversion stents, the rising application of liquid embolic systems, a growing preference for minimally invasive neurointerventions, the evolution of coil technologies featuring advanced coatings, and an enhanced emphasis on precision neurovascular devices.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp
What Drivers Are Influencing The Neurovascular Embolization Devices Market?
The neurovascular embolization devices market is anticipated to expand due to the increasing occurrence of hemorrhages. Hemorrhages are defined as uncontrolled, abnormal bleeding that can manifest internally within the body or externally through the skin or mucous membranes. Factors contributing to the widespread prevalence of hemorrhages include the growing number of elderly individuals, a higher incidence of hypertension, and the broader application of anticoagulant medications. These neurovascular embolization devices find application in hemorrhagic strokes, where they serve to block problematic blood vessels, thereby minimizing bleeding and averting further cerebral harm. For example, research conducted by King’s College London, a UK-based public research university, indicated in February 2024 that a specific form of hemorrhage, intracerebral hemorrhage (ICH), is projected to see an increase of 59.4% in both cases and fatalities among individuals aged 70 to 95 across the UK by the year 2050. Consequently, the rising incidence of hemorrhages is a key factor propelling the expansion of the neurovascular embolization devices market.
Which Market Segments Are Examined In The Neurovascular Embolization Devices Market Study?
The neurovascular embolization devices market covered in this report is segmented –
1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Neurovascular Hemorrhage Management, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
2) By Liquid Embolic Systems: N-Butyl Cyanoacrylate-Based Embolics, Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips
5) By Other Products: Balloons For Embolization, Microcatheters
Which Trends Are Influencing The Neurovascular Embolization Devices Market?
Major companies engaged in the neurovascular embolization devices market are prioritizing the development of cutting-edge solutions, including next-generation flow diverters, to supersede traditional aneurysm treatment approaches. A next-generation flow diverter is characterized by its ability to enhance procedural safety and efficacy by improving vessel wall apposition, minimizing clotting risks, and facilitating easier deployment in complex aneurysm anatomies. For example, in July 2025, Stryker Corporation, a medical technology company based in the US, introduced the Surpass Elite Flow Diverter into its neurovascular product lineup. This innovation replaces older aneurysm treatment devices by delivering minimally invasive flow diversion therapy for large or giant unruptured intracranial aneurysms. It offers superior thrombo-resistance and an optimized braid design, allowing physicians to achieve improved procedural outcomes with reduced manipulation. Integrated with Stryker’s training and physician support programs, it provides a seamless clinical experience. The Surpass Elite Flow Diverter enhances patient safety, simplifies procedural workflows, and helps to expand the adoption of flow diversion therapy in neurovascular care.
Who Are The Primary Competitors In The Neurovascular Embolization Devices Market?
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH, Cerenovus, Sequent Medical Inc
Read the full neurovascular embolization devices market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Neurovascular Embolization Devices Market?
North America was the largest region in the neurovascular embolization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Neurovascular Embolization Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15871&type=smp
Browse Through More Reports Similar to the Global Neurovascular Embolization Devices Market 2026, By The Business Research Company
Tumor Embolization Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Transcatheter Embolization And Occlusion Devices Market Report 2026
Vascular Embolization Market Report 2026
https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model